Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.
about
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsRecovery of endocrine function after islet and pancreas transplantationHLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant RegistryThe immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Improvement in outcomes of clinical islet transplantation: 1999-2010.Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell TransplantationInflammatory response in islet transplantation.Islet assessment for transplantation.Development of pancreas storage solutions: Initial screening of cytoprotective supplements for β-cell survival and metabolic status after hypothermic storage.Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.Immune tolerance induction by integrating innate and adaptive immune regulators.Comprehensive health assessment and five-yr follow-up of allogeneic islet transplant recipients.A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.Anti-caspase-3 preconditioning increases proinsulin secretion and deteriorates posttransplant function of isolated human islets.Stem cell-derived islet cells for transplantationComposite islet-kidneys from single baboon donors cure diabetes across fully allogenic barriers.Portal vein thrombosis is a potentially preventable complication in clinical islet transplantationHypersensitivity to rabbit antithymocyte globulin in an islet transplant recipient: a case reportIslet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes?A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products.β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection.Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetesOptimal control of blood glucose: the diabetic patient or the machine?The Spleen Is an Ideal Site for Inducing Transplanted Islet Graft Expansion in Mice.Persufflation (or gaseous oxygen perfusion) as a method of organ preservationPresent and future cell therapies for pancreatic beta cell replenishment.Assessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy.Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remainPuzzling about partial glucagon responses to hypoglycemia in intrahepatic islet recipients: missing pieces.Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocolIslet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcomeEmbryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model.Current advances and travails in islet transplantation.Oxygenation of the Intraportally Transplanted Pancreatic Islet.Immunological aspects of pancreatic islet cell transplantation.Treatment options for paediatric diabetes.Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events.Pancreatic islet transplantation.Type 1 diabetes: etiology, immunology, and therapeutic strategies.
P2860
Q26752205-FF7E8E8E-A7FD-4532-B1B9-D4A34ADC347DQ26822596-7C6C23C9-311C-47B4-BC63-98F18A0BEA3CQ30405787-1E56E00A-A6F5-4209-AE28-3D8CBF847C2CQ30409961-FA2B49EF-2FF7-4CF4-B3F2-E4F7CDB49CFCQ30418470-3693DB18-A5CB-4FDC-B3F0-48D0545B29CFQ30430008-68BB5144-CC0A-4D42-8453-66E05ADCD501Q30430239-1A744CCE-6E66-4739-8703-E4069798A69AQ33614652-F739D53B-0839-42A5-99CB-6FE1561F5839Q33808574-6BD19CF9-B38E-4239-9F64-8EA4864FF1CCQ33828340-4EC73B2D-EE45-4BBE-BB27-BE84FDEE6B26Q33848529-C68BDD77-37BB-46F7-8807-F252ECECCB84Q33907609-BCEA19E9-9388-465E-8B57-C2DFDC477967Q34045075-59D23711-8E4B-441C-A74D-3D5BD5C1CB9CQ34082857-47A0F672-24BF-406C-B90F-02E3C8EB1090Q34638742-CD383620-702B-499C-876E-D9FF22047227Q35156849-C8FC5577-EBCC-407A-96B6-87A11ED517A8Q35581110-98D275AF-F85A-4686-97BC-42440721937AQ35581203-A4B9ABD9-297F-41C2-8577-376807BC9345Q35602628-2B5841E3-694A-4ACB-AB28-DC9C455C31F7Q35630705-F541A008-6914-4DC3-BE39-8C934C0B1EEEQ35857142-F8815FF2-AF35-4E3F-824C-F8E1FF0E8AE2Q35904021-803078E9-6633-495D-8CD3-AE3B5BF21FE4Q36077883-2BBA0A55-0A56-47DC-97CF-840533ED16A3Q36206226-A33C2E90-4839-431F-A4D2-E7A9109EF4B7Q36263810-747401FA-1913-4ED9-9539-5617A2A63960Q36458671-6C1569F1-811A-4546-8FEF-CF45C45FA660Q36492596-7AC59E2B-2BA8-4C1D-9B7A-34BF44FED191Q36590511-9CE576A8-E77B-43DC-B5A4-8A4C4160A822Q36666407-BCE2BA43-08F0-4A0A-93E7-AC884782223BQ36926310-4885F629-8514-4969-9A1D-0F3B55A3BC32Q37031038-61262F96-D283-480D-83CA-416C62075C8BQ37088225-824DDD50-0B20-44C8-A778-7E9CBD892D8EQ37208835-C1FE5AF0-A404-4E58-B5FD-F415D090B369Q37360411-5869B4FC-32DF-4A86-9A3E-9E075EFA4013Q37410835-A785580E-194A-4E25-9E72-4A1B0EFCC7CFQ37729050-10DEBF11-4CF5-406E-890C-B235C5AD432DQ37776269-05C0CB9B-1E41-431F-8571-35E34DD4F660Q37809052-2E09387F-75AD-42E1-9D92-CDB4B9D74DCCQ37821262-DBBD2E3E-817D-4C94-9765-095900A8C7EAQ37830198-79A4AF57-3D8A-4DA7-A05D-143AA80D94CE
P2860
Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Prolonged insulin independence ...... cipients with type 1 diabetes.
@ast
Prolonged insulin independence ...... cipients with type 1 diabetes.
@en
type
label
Prolonged insulin independence ...... cipients with type 1 diabetes.
@ast
Prolonged insulin independence ...... cipients with type 1 diabetes.
@en
prefLabel
Prolonged insulin independence ...... cipients with type 1 diabetes.
@ast
Prolonged insulin independence ...... cipients with type 1 diabetes.
@en
P2093
P2860
P1476
Prolonged insulin independence ...... cipients with type 1 diabetes.
@en
P2093
A N Balamurugan
B J Hering
D E R Sutherland
J D Ansite
P2860
P304
P356
10.1111/J.1600-6143.2008.02404.X
P407
P577
2008-09-19T00:00:00Z